GSK withdraws from running for Pfizer Consumer Health
March 23, 2018Medical Communications, Sales and Marketing GSK, Pfizer, Pfizer Consumer Health, biotech, drugs, pharma, pharmaceutical
GSK has announced that it has decided to pull out of the race to acquire Pfizer’s Consumer Health business, ending …
Promising drug for hormone therapy-resistant breast cancer enters human trials
March 22, 2018Research and Development TTC-352, breast cancer, chicago, pharma
A team of researchers at Chicago’s University of Illinois (UIC) have revealed that their promising drug which could prove an …
US “right to try” legislation passes after initial defeat
March 22, 2018Medical Communications, Research and Development, Sales and Marketing FDA, House of representatives, Right to try, US, pharma
The controversial and much-discussed “right to try” bill has been passed in the US House of Representatives, quickly rebounding after …
Regeneron-Alnylam team up to treat NASH
March 22, 2018Research and Development, Sales and Marketing Alnylam, Regeneron, biotech, drugs, nash, pharma, pharmaceutical
Coming on the back of a Regeneron research piece published in the New England Journal of Medicine, the company announced …
Bayer-Monsanto deal one step closer, after EU nod
March 22, 2018Sales and Marketing Bayer, EU, biotech, drugs, monsanto, pharma, pharmaceutical
The merger between Bayer and agricultural giant, Monsanto, is inching closer to completion after the EU Commission won EU antitrust …
Sun Pharma receives approval for first biologic drug
March 22, 2018Sales and Marketing Sun Pharma, biotech, drugs, pharma, pharmaceutical
The beginning of Sun Pharma’s diversification out of generic drugs is here and it’s a drug that MSD, known as …
Independent committee report seeks Brexit healthcare clarity
March 21, 2018Medical Communications, Research and Development ABPI, UK, biotech, brexit, drugs, pharma, pharmaceutical
An independent report, entitled Brexit – Medicines, Medical Devices and Substances of Human Origin and written by the Health and …
NICE turns down Dompe’s eye drops for rare eye condition over price concerns
March 21, 2018Manufacturing and Production, Research and Development, Sales and Marketing Dompe, NICE, cenegermin, neurotrophic keratitis, pharma, rare disease
NICE has announced that it has recommended against the use of Dompe’s recombinant human nerve growth factor eye drop therapy …
Takeda completes construction of new global headquarters in Tokyo
March 21, 2018Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Japan, Takeda, pharma, tokyo
Japan’s biggest pharmaceutical firm Takeda has announced the completion of construction of its new global headquarters in the country’s capital …
J&J’s longest-standing CFO finally steps down
March 21, 2018Medical Communications, Research and Development J&J, JJ, Johnson & Johnson, biotech, cfo, drugs, pharma, pharmaceutical
Johnson & Johnson have revealed that its Chief Financial Officer and Executive Vice President, Dominic J. Caruso, will retire from …
Celgene bucks trend to strengthen neuroscience pipeline
March 21, 2018Research and Development, Sales and Marketing Alzheimer's, Celgene, Prothena, biotech, drugs, neuroscience, pharma, pharmaceutical
Celgene has gone against industry movement to back out of the neuroscience area by putting down a potential $2.2 billion …
Heron soars after its painkiller agent reduces pain and opioid use post-surgery at Phase 3
March 20, 2018Manufacturing and Production, Research and Development heron therapeutics, opioid crisis, opioid epidemic, opioids, painkiller, pharma
Heron Therapeutics has been buoyed by the news that its painkiller agent HTX-011 met all of its primary and secondary …
Novartis steps into the medical marijuana business
March 20, 2018Manufacturing and Production, Sales and Marketing Medical marijuana, Novartis, Sandoz, biotech, drugs, pharma, pharmaceutical
Canada’s burgeoning medical marijuana industry has finally drawn in a big pharma player. Tilray, a producer of medical cannabis products, …
Regeneron’s Eylea smashes Phase 3 trial goal in diabetic retinopathy
March 20, 2018Manufacturing and Production, Research and Development Eylea, Regeneron, diabetes, pharma
Regeneron has confirmed that its vascular endothelial growth factor (VEGF) inhibitor injection Eylea (aflibercept) met its primary endpoint in a …
Roche’s immunotherapy improves PFS but unclear long-term benefit in lung cancer
March 20, 2018Manufacturing and Production, Research and Development Roche, biotech, drugs, pharma, pharmaceutical, tecentriq
Roche’ Tecentriq needs a big result in the immunotherapy space – it initially burst onto the scene as a third-to-market …
Vertex “astonished” by NHS England’s response to CF drug
March 20, 2018Manufacturing and Production, Sales and Marketing Vertex, biotech, cystic fibrosis, drugs, pharma, pharmaceutical
Vertex has been battling to have its treatment, Orkambi, approved in the UK since 2016, when it was first rejected …
New Chief Science and Medical Officers for Gilead
March 19, 2018Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Gilead, appointment
Gilead has announced that Dr Norbert Bischofberger, its Chief Scientific Officer (CSO), Executive Vice President of Research and Development and …
Male contraceptive pill hits safety goals
March 19, 2018Research and Development, Sales and Marketing biotech, drugs, male contraceptive, pharma, pharmaceutical
A male contraceptive pill may be edging closer to the market, after a new formulation was shown to be safe …
Working Life: Chris Round, Head of EMEA Region, Merck KGaA
March 19, 2018Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Chris Round, MSD, Merck, Merck KGaA, Working Life, pharma
Merck KGaA’s Chris Round, Head of EMEA Region, spoke with Pharmafile.com to discuss his time at both the US and …
“Game-changer” stem cell transplant shows strength in multiple sclerosis
March 19, 2018Research and Development, Sales and Marketing Stem cells, multiple sclerosis, pharma
A new stem cell transplant is being hailed as a “game-changer” in the treatment of multiple sclerosis (MS) after an …
Latest content
Global coalition calls for stronger government action on COPD
Global health researchers call for more equitable partnerships
Liverpool launches £20m lab for infectious disease drug discovery
Circle Health Group expands into UK laboratory operations
